 |
anufacturing Competence
- Dry Powder for injection
- Liquid sterile Injection
- Encapsulated Formulations
- Sachets
- Capsules
anufacturing Facilities
UNITEX-TENAMYD CANADA Pvt. Ltd. has three independent finished-product manufacturing facilities for solid, liquid, semi-solid, liquid injection and dry powder injection dosage forms.
A Manufacturing site having independent B-lactum and non B-lactum blocks, Capsules (General ,B-lactum), Dry Suspension (B-lactum), Ophthalmic Preparation, Small Volume Parenteral Injections (S.V.P) Liquid Injection, Dry Powder Injection (B-Lactum and General).
The plant provides Novel Gel delivery systems, and Innovative Soft Gelatin Dosage Forms. Multi-vitamins + Multi-minerals Oil based capsules, Pessaries, Suppositories, Chewable Tablets, Soft Gelatin capsules, Gelatin free vegetarian soft capsules.
Solid-oral-dosage forms manufacturing facility for Tablets -coated & uncoated (General), Capsules (B-lactum), Oral Suspensions (bottles and sachets B-lactum and general). The Facility is equipped to manufacture OTC, branded and generic products.
anufacturing compliance
We manufacture our products in WHO-GMP Approved manufacturing facilities equipped with state -of -art equipments.
WHO- GMP approval is an assurance that our products are consistently produced and controlled in such a way to meet the quality standards appropriate to the intended use, as required by the marketing authorization of that country.
We manufacture our products in facilities that are all regularly evaluated and upgraded so that they meet the current stringent regulatory requirements of various regulatory bodies across the globe; this ensures that the finished products manufactured in these facilities have the desired identity, strength, quality and purity.
UK MHRA Compliance implies that:
- Our medications work and are acceptably safe.
- No product is risk-free but we ensure that the product’s benefits to patients and the public justify the risks.
- Introduction of innovative treatments and technologies that benefit patients and the public.
top
|
|
| |
|
